Value Investing Philosophy And Haemonetics Corp. (NYSE: HAE)?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Haemonetics Corporation Completes Acquisition of Attune Medical.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

HAE belongs to the Healthcare sector of the NYSE while operating in the Medical Instruments & Supplies industry. At the end of the last regular session, the stock closed at $84.17 and fluctuated between $85.08 as its day high and $83.13 as its day low. The current market capitalization of Haemonetics Corp. is $4.27B. A total of 0.51 million shares were traded on the day, compared to an average of 458.06K shares.

In the most recent transaction, Strong Stewart W sold 228 shares of HAE for 90.65 per share on Sep 12 ’23. After the transaction, the President, Global Hospital now owns 16,221 company shares. In a previous transaction on Sep 11 ’23, Lingamneni Anila sold 2,305 shares at 90.00 per share. HAE shares that EVP, Chief Technology Officer owns now total 14,495.

Among the insiders who sold shares, Dockendorff Charles J disposed of 10,215 shares on Sep 05 ’23 at a per-share price of $87.68. This resulted in the Director holding 2,226 shares of HAE after the transaction. In another insider transaction, Llorens Josep sold 4,928 shares at $90.00 per share on Jul 18 ’23. Company shares held by the EVP, Global Manufacturing now total 18,463.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, HAE has a high of $95.26 and a low of $70.74.

As of this writing, HAE has an earnings estimate of $0.89 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of $0.92 per share and a lower estimate of $0.88. The company reported an EPS of $0.99 in the last quarter, which was 11.20% higher than expectations of $0.89.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. HAE’s latest balance sheet shows that the firm has $259.50M in Cash & Short Term Investments as of fiscal 2022. There were $773.59M in debt and $442.27M in liabilities at the time. Its Book Value Per Share was $18.57, while its Total Shareholder’s Equity was $749.42M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HAE is Buy with a score of 4.17.

Most Popular

Related Posts